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Ultrasound should be used as an adjunct in the diagnosis.
Empiric therapy covering Staphylococcus aureus is prudent
pending culture reports.
http://dx.doi.org/10.1016/j.ijid.2016.02.347
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Virulence gene proﬁle and SCCmec types of
clinical MRSA isolates: Is there a ﬁtness cost
involved?
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Background: The success ofmethicillin resistant Staphylococcus
aureus as a pathogen is attributed to its extraordinary repertoire of
virulence factors. BasedonSCCmec types,MRSA isolates canbeclas-
siﬁed as hospital (HA-MRSA) or community acquired (CA-MRSA).
Association of certain virulence geneswith particular SCCmec types
has been previously reported. For instance, pvl gene is associated
with SCCmec types IV or V (CA- MRSA types).
Methods & Materials: Two hundred non-repetitive isolates of
MRSA from clinical specimens were screened for virulence genes
such as pvl, tsst, hlg, enterotoxin A (sea), exfoliative toxin A (eta),
intercellular adhesion (ica) genes by PCR. SCCmec typing was car-
ried out by multiplex PCR. An attempt was made to ﬁnd the
association between virulence genes and the clinical presentation
aswell as with the SCCmec types to establish the ﬁtness cost, if any.
Results: A total of 192 isolates (96%) carried one or more viru-
lence genes while 8 (4%) had none. The commonest virulence gene
encountered was ica (90%) followed by hlg (83%), sea (78%), pvl
(53%), eta (12%) and tsst (2%). Out of 200 MRSA isolates, only 40%
carried single SCCmec type, whereas 59% carried multiple SCCmec
types including a combination of classical HA and CA types. The
predominant SCCmec type found in our study was III followed by
SCCmec V. eta and pvl toxins were mainly encountered in isolates
from severe skin and soft tissue infections whereas the isolates
which were negative for the virulence genes tested were obtained
from mild skin infections. Notably, all the blood isolates (n=12)
were negative for pvl and eta, whereas all were positive for hlg.
pvl gene positivity was signiﬁcantly associated with SCCmec type
V followed by type III. Majority of the blood isolates and all the tsst
positive MRSA isolates carried SCCmec III. The single isolate with
SCCmec type II was negative for all the virulence genes tested.
Conclusion: This study documented the presence of virulence
genes in various combinations in majority of the clinical MRSA iso-
lates. No strong evidence for ﬁtness cost of SCCmecwas established
as the isolates negative for virulence genes belonged to diverse
SCCmec types.
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Background: The explosion of interest in the human micro-
biome research was sparked in part by two research initiatives
launched in 2008, the European and Chinese-led Metagenomics
of the Human Intestinal Tract Consortium and the National Insti-
tutes of Health (NIH)-sponsored Human Microbiome Project. The
new knowledge provided by these initiatives and others world-
wide are transforming our understanding of the pathogenesis of
several diseases, including asthma, inﬂammatory bowel diseases,
obesity and Type 1 diabetes, as well as the development of the
immune response linked to some vaccines. However, African popu-
lations areunderstudied in these initiatives, and there is no “African
Microbiome Initiative”. This systematic review aimed to summa-
rize and discuss the state of research on the human microbiome
in Africa, including the therapeutic role of the microbiome for the
management of certain local diseases.
Methods&Materials: Using predeﬁnedkeywords,we searched
in six electronic databases for human microbiome studies con-
ducted in Africa. In addition, to ﬁnd additional articles, we checked
references cited in eligible studies. Two authors independently
selected eligible studies published until 30 September 2015.
Results: Eighty-nine human microbiome papers were identi-
ﬁed from six electronic databases and other sources. Therewere 80
primarymicrobiomestudies (includingKhoi San (n=1) andHunter-
Gatherers (n= 4)) and 9 nested microbiome studies within existing
cohorts. 16S rRNA gene sequencingwas the techniquemostwidely
used to characterize the microbiota. The main body sites studied
were the gut (46%), vagina (25%) and the oral cavity (11%). The dis-
eases targetedweremalnutrition (n= 4), HIV/AIDS (n= 7), diarrhoea
(n= 4), and periodontitis (n= 5). These microbiome studies were
performed in individuals of all ages, with most of the studies being
conducted in adults. Kenya, Uganda, South Africa and Nigeria were
the sites of the majority of studies; however the principal investi-
gators of most of the studies (87%) were from developed countries.
TheUSANIHwas themain fundingsource (25%), followedby theBill
and Melinda Gates Foundation (9%) and the European Commision
(8%).
Conclusion: More studies of the microbiome including African
participants, focusing on endemic diseases and led by African
researchers are needed.
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